Labshake search
Citations for R&D Systems :
1551 - 1600 of 3688 citations for En 1948 4 Marker Pcb Extraction Spike 13C12 99% 100 Ng Ml In Nonane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... or 4 μg/mL of anti-CCL1 Ab (clone 148113; R&D Systems), was added to the cultures.
-
bioRxiv - Immunology 2022Quote: ... 4 μg/mL of anti-CCL5 Ab (polyclonal goat IgG; R&D Systems), or 4 μg/mL of anti-CCL1 Ab (clone 148113 ...
-
bioRxiv - Bioengineering 2023Quote: ... or 4 µg mL-1 human PDGFR beta antibody (AF385, R&D Systems) and 10 µg mL-1 human/mouse/rat alpha-smooth muscle actin antibody (MAB1420 ...
-
bioRxiv - Immunology 2021Quote: ... 115-006-068), 250ng/ml mouse recombinant MEGACD40L (Enzo, ALX-522-120) and 20ng/ml Recombinant mouse IL-4 (R&D system, 404-ML). Cells were collected at specific time points for analysis ...
-
bioRxiv - Cancer Biology 2021Quote: ... Wild-type cultures were also supplemented with 500 ng/mL R-spondin (R&D Systems #3474-RS). For ex vivo growth assays ...
-
bioRxiv - Cell Biology 2020Quote: ... cells were cultured in the presence of M-CSF (30 ng / mL; R&D Systems, Minneapolis, USA), and with RANKL (10 ng / mL ...
-
bioRxiv - Microbiology 2019Quote: ... L-glutamine (2mM) and 50 ng/mL of recombinant human M-CSF (R&D Systems, Minneapolis, Minnesota) for 6 to 7 days to differentiate them to macrophages [41] ...
-
bioRxiv - Neuroscience 2021Quote: ... The medium was supplemented with 20 ng/ml epidermal growth factor (EGF, #236-EG; R&D Systems) and 20 ng/ml basic fibroblast growth factor (bFGF ...
-
bioRxiv - Physiology 2019Quote: ... for 72 hours prior to stimulation with 10 ng/mL IFN-α (R&D Systems, 11101-2). Media was prepared by adding 120 μL of 10 mg/mL stock 13C11 15N2 L-tryptophan in 1x PBS to 240 mL of RPMI (Corning ...
-
bioRxiv - Bioengineering 2020Quote: ... 2) transforming growth factor beta-2 (TGF-β2; 2.5 ng/ml; R&D Systems, Minneapolis, MN, USA), 3 ...
-
bioRxiv - Cell Biology 2021Quote: ... following 5 min of stimulation with 10 ng/mL PDGF-AA or PDGF-BB (R&D Systems) for the PDGFRα homodimer and PDGFRβ homodimer cell lines ...
-
bioRxiv - Cell Biology 2021Quote: ... Osteoclast differentiation was induced by treatment with 25 ng/ml M-CSF (R&D Systems, Abingdon, UK) and 50 ng/ml RANKL (Peprotech ...
-
bioRxiv - Immunology 2022Quote: ... 1% penicillin/streptomycin (Cytiva, Marlborough, MA) and 20 ng/mL GM-CSF (R&D Systems, Minneapolis, MN) (DC media ...
-
bioRxiv - Cancer Biology 2020Quote: idAdpgkG MC38 cells were treated with 20 ng/mL mouse interferon γ (mIFNγ, R&D Systems, Inc.) alone for 51 h prior to harvest (“control” condition) ...
-
bioRxiv - Neuroscience 2022Quote: ... the medium was changed to that which contained 25 ng/ml mouse GM-CSF (R&D Systems). The primary microglia were harvested by shaking (200 rpm ...
-
bioRxiv - Molecular Biology 2019Quote: ... Differentiation toward germ layers was induced by addition of 50 ng/mL of BMP4 (R&D Systems) to mTeSR1 media ...
-
bioRxiv - Immunology 2020Quote: ... over 7 days followed by 18 h treatment with IFN-γ (20 ng/ml; R&D Systems) plus LPS (100 ng/ml ...
-
bioRxiv - Molecular Biology 2022Quote: ... 10 ng/ml recombinant human brain-derived neurotrophic factor (BDNF) protein (R&D Systems 248-BDB-005), and 10 µM ɣ-secretase inhibitor (DAPT ...
-
bioRxiv - Cell Biology 2022Quote: ... Cells were then treated with 10 ng/ml of recombinant human EGF (236-EG, R&D systems) in RPMI-1640 medium and incubated at 37℃ ...
-
The MuSK-BMP pathway maintains myofiber size in slow muscle through regulation of Akt-mTOR signalingbioRxiv - Cell Biology 2022Quote: ... then treated with 20-25 ng/ml recombinant human BMP4 protein (R&D Systems, Cat# 314-BP). For acetylcholine receptor clustering experiments ...
-
bioRxiv - Developmental Biology 2022Quote: ... Embryos were treated with 150 ng/ml of recombinant mouse BMP2 protein (355-BEC, R&D Systems Inc ...
-
bioRxiv - Neuroscience 2022Quote: ... and 25 ng/ml (422.6 nM) Hyper-IL-6 (R&D Systems, Cat. no. 8954-SR-025) at day 45 of differentiation ...
-
bioRxiv - Neuroscience 2022Quote: ... containing medium supplemented with BDNF (20 ng/ml; catalog#248-BDB, R&D Systems, Minneapolis, MN, USA), cAMP (0.5 mM ...
-
bioRxiv - Neuroscience 2023Quote: ... coated 6 well plates in oRIM supplemented with 2.6 nM (20 ng/mL) IGF1 (R&D Systems). On day 24 ...
-
bioRxiv - Microbiology 2023Quote: ... to promote M1-differentiation or 20 ng/ml macrophage colony-stimulating factor (M-CSF; R&D Systems) to promote M2-differentiation as previously described [9] ...
-
bioRxiv - Neuroscience 2023Quote: ... medium was replaced with EB medium supplemented with Sonic Hedgehog (SHH; 20 ng/mL, R&D Systems) and fibroblast growth factor 8 (FGF8 ...
-
bioRxiv - Genetics 2023Quote: ... and receptor activator of nuclear factor kappa-B ligand (RANKL) (2 ng/mL; R&D systems; USA) to induce osteoclastogenesis ...
-
bioRxiv - Cancer Biology 2022Quote: ... unconditioned HEI-193 media supplemented with recombinant human CCL21 600 ng/ml (366-6C, R&D Systems) as a positive control ...
-
bioRxiv - Immunology 2023Quote: ... stimulation medium (2X concentration) was prepared by adding 400 ng/mL HA-tagged rhCD40L (R&D Systems) and 100 ng/mL anti-HA tag antibody (clone 543851 ...
-
bioRxiv - Biochemistry 2023Quote: ... 20 ng/mL recombinant mouse tumor necrosis factor-α (TNF-α) (R&D Systems, 41-0MT0-25CF) and 12 ng/mL recombinant mouse IFN-γ were added to the media.
-
bioRxiv - Molecular Biology 2023Quote: ... goat anti-mouse IL-1β polyclonal antibody (250 ng ml−1; R&D Systems, AF-401-NA) rabbit anti-mouse caspase-1 + p10 + p12 monoclonal antibody (1.87 µg ml−1 ...
-
bioRxiv - Bioengineering 2023Quote: ... medium was changed every day to HDM with 20 ng/mL human recombinant HGF (R&D Systems). After 14 to 24 days ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) (50 ng/mL) (R&D Systems) and recombinant human interleukin-4 (IL-4 ...
-
bioRxiv - Immunology 2024Quote: ... dFBs were treated with either recombinant mouse IFNγ (5 ng/ml, R&D Systems, Minneapolis, MN, USA) for 8 or 24 hours before being subjected to qRT-PCR or ELISA analysis.
-
bioRxiv - Microbiology 2023Quote: ... Monocyte-derived macrophages were differentiated from primary monocytes by 50 ng/ml GM-CSF (R&D Systems) treatment for 6-10 days ...
-
bioRxiv - Cell Biology 2023Quote: ... following 5 min of stimulation with 10 ng/ml PDGF-BB (R&D Systems, Minneapolis, MN, USA) in the case of the PDGFRαV1/βV2 heterodimer cell line ...
-
An endothelial SOX18-mevalonate pathway axis enables repurposing of statins for infantile hemangiomabioRxiv - Molecular Biology 2024Quote: ... The medium was replaced with fresh differentiation medium containing 10 ng/mL VEGF-B (R&D Systems) every two days ...
-
bioRxiv - Bioengineering 2024Quote: ... which was supplemented with 3 ng/mL human activin A (R&D Systems, Inc., Minneapolis, MN, USA), 1 ng/mL human bone morphogenetic protein 4 (Bmp4 ...
-
bioRxiv - Cell Biology 2024Quote: ... and 125 ng/mL Fibroblast growth factor (FGF) -8b (423-F8-025/CF; R&D Systems Inc) to DPSC-BM as previously reported [35] ...
-
bioRxiv - Cancer Biology 2024Quote: ... Cells were stimulated with recombinant mouse VEGF-A (300 ng/mL, R&D Systems #493-MV-005), recombinant mouse VEGF-B186 (300 ng/mL) ...
-
bioRxiv - Cell Biology 2019Quote: ... and expanded chondroprogenitor cells were re-suspended at 2.5 × 105 cells / mL in chondrogenic medium supplemented with 10 ng/ml human transforming growth factor beta 3 (TGF-β3; R&D Systems, Minneapolis, MN). Chondrogenic pellets were cultured at 37°C for 28 days ...
-
bioRxiv - Neuroscience 2020Quote: ... L-glutamine and 10 ng/ml of carrier-free murine recombinant granulocyte and macrophage colony-stimulating factor (GM-CSF, 415-ML, R&D systems, Minneapolis, MN). Cell suspension from one brain was plated in a T75-cell culture flask coated with poly-D-lysine (P7280 ...
-
bioRxiv - Cell Biology 2020Quote: ... were covered with HUVECs and embedded 24 hours later in a 2,5 mg/mL fibrin gel in the presence or absence of VEGFA-165 at 5 ng/mL (R&D systems, Minneapolis MN, USA). Conditioned media from papillary or reticular fibroblasts were added on top of the gel and renewed every day for four days ...
-
bioRxiv - Developmental Biology 2021Quote: ... 30 ng/ml Activin [cat. num. 338-AC; R&D Systems, Minneapolis, MN], 20 ng/ml FGF2 [cat. num. 233-FB-025/CF; R&D Systems, Minneapolis ...
-
bioRxiv - Immunology 2021Quote: ... magnetically isolated T cells were resuspended in the complete medium and were seeded in a 10-cm petri dish or T-75 flask at 1–2×106 cells/cm2 and cultured in the presence of 20 ng/mL recombinant mouse interleukin-7 (rmIL-7; 402-ML-020/CF, R&D Systems, Minneapolis, MN) for 24 hr at 37°C in a humidified 5% CO2 atmosphere.
-
bioRxiv - Immunology 2022Quote: ... Five million PBMC were suspended in 40 ml R10 supplemented with 10 ng/ml recombinant human IL-2 (R&D Systems, 202-IL-050) together with 10 million K562-mbIL21-41BBL feeder cells irradiated with 100 Gy ...
-
bioRxiv - Cell Biology 2023Quote: ... non-adherent hematopoietic progenitors were pooled and plated at 7x104 cell/well (96-well) with complete media supplemented with 30 ng/mL M-CSF (R&D Systems, 416-ML). At 90% confluence ...
-
bioRxiv - Immunology 2022Quote: ... and MΦs with IL-4 (20ng/ml) and IL-13 (20ng/ml; denoted ‘IL4/13’ for brevity; R&D Systems) in MΦ media ...
-
bioRxiv - Cell Biology 2023Quote: ... supplemented with FGF2 (4 ug/mL; Biochemistry Department, University of Cambridge) and TGF-β1 (1.74 ug/mL; R&D Systems) using Vitronectin XF (STEMCELL Technologies ...
-
bioRxiv - Neuroscience 2023Quote: ... The cells were labeled with anti-human SSEA-4 APC-conjugated antibody (1:100, R&D Systems) at 37°C for 30 minutes ...